Chemomab Therapeutics Ltd. (CMMB) AI Dilution Summary

Cash was $6,687,000 at 2026-06-30 against estimated monthly burn of $624,000. The funding channel is the active ATM program with LifeSci Capital LLC, authorised to $7,258,687, through which 2,014,746 shares were sold since the program began through 2026-06-30; sales after 2026-06-30 are not yet reported, and the most recent capital raised was ATM sales through that date.